A new surgical technology has been invented in Israel that will radically transform how surgery is performed around the world. The groundbreaking health technology, called ExAblate, combines MRI and Focused Ultrasound to non-invasively treat tumors inside the body without the need for incisions.
By combining the two technologies, the anatomy of the body is visualized, and the treatment can be planned and outcome monitored in real time. During this outpatient procedure, the patient lies inside an MRI scanner, which provides three-dimensional images of the diseased tissue and surrounding area, enabling the ultrasound waves to be precisely guided.
Praised by many as the ‘operating room of the future’, this technology has been predicted to replace standard operations with non-invasive outpatient procedures within the next decade. By treating tumors without incisions, recovery time is lessened and the risk for infections and other surgical complications is reduced.
Already approved to treat uterine fibroids, ExAblate is currently used in Israel, the United States, Europe and Asia. Over 8,000 patients have been treated worldwide with the system, and clinical trials are currently being conducted to evaluate ExAblate for treatment of other diseases, such as breast, liver and brain cancers.